Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Lattice Semiconductor Corporation Common Stock (LSCC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Lattice Semiconductor Corporation Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $109.92 (market cap $12.58B), while Lattice Semiconductor Corporation Common Stock trades at $127.91 (market cap $17.76B). The key difference: Lattice Semiconductor Corporation Common Stock is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Lattice Semiconductor Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Lattice Semiconductor Corporation Common Stock for 0 Days on average.
| HALO | LSCC | |
|---|---|---|
Market Cap | $12.58B | $17.76B |
Volume | 2,179,278 | 1,802,283 |
Sector | Health | Technology |
52-Week High | $115.22 | $155.27 |
52-Week Low | $61.63 | $61.73 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.49B | $17.62B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Lattice Semiconductor Corporation Common Stock
Lattice Semiconductor develops low-power programmable chips, known as FPGAs. Its products are used in communications, computing, industrial, and automotive applications.
Read more on LSCC →
